Morepen Laboratories Limited (BOM: 500288)

Morepen Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	553.83	169.45	216.66	158.03	413.87	136.39
Short-Term Investments	1,310	-	-	-	-	-
Cash & Short-Term Investments	1,864	169.45	216.66	158.03	413.87	136.39
Cash Growth	222.30%	-21.79%	37.10%	-61.82%	203.44%	41.81%
Accounts Receivable	3,002	3,249	2,632	2,506	1,820	1,377
Other Receivables	-	63.51	26.03	31.57	88.3	45.77
Receivables	3,004	3,315	2,661	2,541	1,911	1,426
Inventory	2,824	2,486	2,289	2,759	1,753	1,385
Prepaid Expenses	-	100.71	45.3	21.21	11.75	14.01
Other Current Assets	3,237	2,819	2,350	1,864	1,178	760.53
Total Current Assets	10,930	8,890	7,562	7,343	5,268	3,722
Property, Plant & Equipment	2,698	2,377	1,840	1,608	1,312	1,341
Long-Term Investments	13.01	13.01	-	-	10.85	10.85
Goodwill	744.74	744.74	744.74	744.74	744.74	744.74
Other Intangible Assets	292.74	196.68	254.99	306.77	207.65	78.07
Other Long-Term Assets	943.63	710.26	702.95	697.5	1,037	737.64
Total Assets	15,623	12,932	11,105	10,701	8,581	6,635
Accounts Payable	2,946	2,950	2,269	2,581	2,088	1,723
Accrued Expenses	-	291.46	250.44	207.37	202.25	155.32
Short-Term Debt	-	234.91	231.8	161.32	153.24	113.6
Current Portion of Long-Term Debt	297.6	21.44	10.51	1,158	1,205	1,208
Current Income Taxes Payable	-	166	79.6	101.51	39.67	15.44
Other Current Liabilities	821.07	356.36	370.5	355.53	348.9	298.69
Total Current Liabilities	4,065	4,020	3,212	4,565	4,038	3,514
Long-Term Debt	37.35	33.64	9.34	13.21	8.28	9.25
Long-Term Deferred Tax Liabilities	22.5	22.5	26.86	24.83	-	-
Other Long-Term Liabilities	393.37	117.28	106.99	108.22	103.98	96.99
Total Liabilities	4,518	4,460	3,580	4,920	4,339	3,799
Common Stock	1,096	1,022	1,022	955.59	899.59	899.59
Additional Paid-In Capital	-	3,698	3,698	2,318	1,674	1,674
Retained Earnings	-	2,862	1,900	1,513	546.54	-424.32
Comprehensive Income & Other	10,008	890.39	908.8	998.61	1,127	691.29
Total Common Equity	11,104	8,472	7,529	5,786	4,247	2,841
Minority Interest	-	-	-4.6	-4.61	-4.59	-4.63
Shareholders' Equity	11,104	8,472	7,524	5,781	4,243	2,836
Total Liabilities & Equity	15,623	12,932	11,105	10,701	8,581	6,635
Total Debt	334.95	289.99	251.64	1,332	1,367	1,331
Net Cash (Debt)	1,529	-120.54	-34.98	-1,174	-953.11	-1,195
Net Cash Per Share	2.94	-0.24	-0.07	-2.26	-2.11	-2.66
Filing Date Shares Outstanding	536.13	511.17	511.17	477.83	449.83	449.83
Total Common Shares Outstanding	536.13	511.17	511.17	477.83	449.83	449.83
Working Capital	6,865	4,870	4,350	2,778	1,230	207.33
Book Value Per Share	20.71	16.57	14.73	12.11	9.44	6.31
Tangible Book Value	10,067	7,531	6,529	4,734	3,295	2,018
Tangible Book Value Per Share	18.78	14.73	12.77	9.91	7.33	4.49
Land	-	14.33	14.33	14.33	15.82	15.82
Buildings	-	996.08	908.72	814.08	792.56	766.15
Machinery	-	3,736	4,036	3,804	4,194	5,514
Construction In Progress	-	244.52	170.14	141.46	19.56	-

Source: S&P Capital IQ. Standard template. Financial Sources.